US Patent Issued to INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY on Dec. 16 for "Inflammatory diseases, comprising Lactobacillus sakei CVL-001 strain" (South Korean Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,319, issued on Dec. 16, was assigned to INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (Gwangju, South Korea).

"Inflammatory diseases, comprising Lactobacillus sakei CVL-001 strain" was invented by Jong Hwan Park (Gwangju, South Korea) and Dong Yeon Kim (Gwangju, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition for preventing or treating inflammatory diseases, comprising a Lactobacillus sakei CVL-001 strain. The composition activates NOD2, which is an inflammation regulator, and exhibits the effects of inhibiting weight loss and improving clinical activity scores (disease activity index; D...